Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - BioLabs, Inc. (AMEX:GBI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Location
#1A - 3033 King George Highway
British Columbia V4P 1B8
Surrey, Canada
Phone: (604) 542-0820
Fax: (604) 542-0821
Email: irinfo@gnsbio.com
Employees (last reported count): 2
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 16%
·Institutional: 0% (0% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
BioLabs, Inc., doing business as Genesis Bioventures (GBI), utilizes the scientific and business management expertise of its management team to evaluate and select promising early stage biotechnology companies for investment. As a financial facilitator in the biotech sector, the Company is actively involved with its portfolio companies and serves as a strategic advisor in key aspects of science, product commercialization, business issues and financial development by providing management expertise aimed at transforming promising medical technology into successful commercial products. These portfolio companies typically have products in the earlier stages of development prior to initiation of clinical trials. As of December 31, 2000 GBI has investments in three portfolio companies, with two in the field of oncology and one in neurology.
More from Market Guide: Expanded Business Description

Financial Summary
GBI is engaged in the business of identifying promising biotechnology companies, acquiring an equity interest in these groups and providing management services to assist with their corporate development. For the six months ended 6/30/01, the Company reported no revenues. Net loss totalled $5.7 million, up from $1.6 million. Results reflects increased salary and benefit expenses and increased management and consulting fees.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

E. Greg McCartney, 49
Chairman, Pres, CEO
$91K
T.J. Louis McKinney, 66
CFO, Director
--  
Lawrence Pasemko, 64
Exec. VP, Director
91K
Ian Woods, M.D., Ph.D., 56
VP, Science and Technology,
61K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:GBIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 19-Apr-2001
$1.05 
Recent Price$1.90 
52-Week High
on 1-Dec-2000
$4.875
Beta-1.03 
Daily Volume (3-month avg)38.1K
Daily Volume (10-day avg)46.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-52.5%
52-Week Change
relative to S&P500
-36.3%
Share-Related Items
Market Capitalization$30.1M
Shares Outstanding15.8M
Float13.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.49 
Earnings (ttm)-$0.92 
Earnings (mrq)-$0.22 
SalesN/A 
Cash (mrq)$0.02 
Valuation Ratios
Price/Book (mrq)3.86 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$3.56M
Income available to common (ttm)-$10.6M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-114.48%
Return on Equity (ttm)-152.83%
Financial Strength
Current Ratio (mrq)0.36 
Debt/Equity (mrq)0 
Total Cash (mrq)$259.0K
Short Interest
As of 9-Mar-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume7,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.